Patents by Inventor Gunjan H. Junnarkar

Gunjan H. Junnarkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sustained release small molecule drug formulation
    Patent number: 11110093
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having a Cmax to Cmin ratio of less than 200 and a lag time less than 0.2.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: September 7, 2021
    Assignee: INDIVIOR UK LIMITED
    Inventors: Andrew S. Luk, Gunjan H. Junnarkar, Guohua Chen
  • SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
    Publication number: 20200046704
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having a Cmax to Cmin ratio of less than 200 and a lag time less than 0.2.
    Type: Application
    Filed: July 15, 2019
    Publication date: February 13, 2020
    Inventors: Andrew S. Luk, Gunjan H. Junnarkar, Guohua Chen
  • Sustained release small molecule drug formulation
    Patent number: 10406160
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having a Cmax to Cmin ratio of less than 200 and a lag time less than 0.2.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: September 10, 2019
    Assignee: INDIVIOR UK LIMITED
    Inventors: Andrew S. Luk, Gunjan H. Junnarkar, Guohua Chen
  • SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
    Publication number: 20180325905
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having a Cmax to Cmin ratio of less than 200 and a lag time less than 0.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 15, 2018
    Inventors: Andrew S. LUK, Gunjan H. JUNNARKAR, Guohua CHEN
  • Sustained release small molecule drug formulation
    Patent number: 10058554
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having Cmax to Cmin ratio less than 200 and lag time less than 0.2.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: August 28, 2018
    Assignee: Indivior UK Limited
    Inventors: Andrew S. Luk, Gunjan H. Junnarkar, Guohua Chen
  • SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
    Publication number: 20170239252
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having Cmax to Cmin ratio less than 200 and lag time less than 0.2.
    Type: Application
    Filed: February 2, 2017
    Publication date: August 24, 2017
    Applicant: DURECT CORPORATION
    Inventors: Andrew S. LUK, Gunjan H. JUNNARKAR, Guohua CHEN
  • Sustained release small molecule drug formulation
    Patent number: 9597402
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having Cmax to Cmin ratio less than 200 and lag time less than 0.2.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: March 21, 2017
    Assignee: DURECT CORPORATION
    Inventors: Andrew S. Luk, Gunjan H. Junnarkar, Guohua Chen
  • SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
    Publication number: 20150231258
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having Cmax to Cmin ratio less than 200 and lag time less than 0.2.
    Type: Application
    Filed: April 30, 2015
    Publication date: August 20, 2015
    Applicant: DURECT CORPORATION
    Inventors: Andrew S. LUK, Gunjan H. JUNNARKAR, Guohua CHEN
  • Sustained release small molecule drug formulation
    Patent number: 9044450
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having Cmax to Cmin ratio less than 200 and lag time less than 0.2.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: June 2, 2015
    Assignee: DURECT CORPORATION
    Inventors: Andrew S. Luk, Gunjan H. Junnarkar, Guohua Chen
  • Sustained release small molecule drug formulation
    Patent number: 8852638
    Abstract: An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small molecule drug incorporated in the viscous gel such that the formulation exhibits an in vivo release profile having Cmax to Cmin ratio less than 200 and lag time less than 0.2.
    Type: Grant
    Filed: September 26, 2006
    Date of Patent: October 7, 2014
    Assignee: Durect Corporation
    Inventors: Andrew S. Luk, Gunjan H. Junnarkar, Guohua Chen